The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?

Lately there are many new, promising low-density lipoprotein cholesterol reducing therapies with PCSK9 inhibitors. We performed selected sampling of the publications in PubMed and made a review according to selected keywords. It summarizes the effect of PCSK9 on vascular aging, directly associated w...

Full description

Bibliographic Details
Main Authors: Malwina Grobelna, Ewa Strauss, Zbigniew Krasiński
Format: Article
Language:English
Published: Termedia Publishing House 2019-10-01
Series:Polish Journal of Thoracic and Cardiovascular Surgery
Subjects:
Online Access:https://www.termedia.pl/The-role-of-proprotein-convertase-subtilisin-kexin-type-9-PCSK9-in-the-vascular-aging-process-is-there-a-link-,40,37944,1,1.html